The increased Sp1 expression was observed in several types of cancers, including lung cancer, pancreatic cancer, colon cancer, gastric cancer, and glioma cancer, and is associated with a poor prognosis in some cancers [20,21,22,23]. This evidence concerns the gene SP1 and pancreatic neoplasm.